© 2002 European Society of Cardiology
C-reactive protein as a predictor of improvement and readmission in heart failure
a Department of Internal Medicine, Hospital de Navarra Irunlarrea 3, 31008 Pamplona, Spain
b Department of Cardiology, Hospital de Navarra Irunlarrea 3, 31008 Pamplona, Spain
* Corresponding author E-mail address: jalonsom{at}cfnavarra.es
 |
Abstract |
|---|
Objectives: Only recently, new risk factors to explain atherosclerotic disease have been identified. One of the most important clinical manifestations of atherosclerosis is heart failure. Our study was aimed at investigating C-reactive protein (CRP), a marker of systemic inflammation, in the context of heart failure, and to determine its usefulness in predicting the need for readmission in patients with heart failure and their degree of improvement.
Design: We studied patients admitted to our hospital due to heart failure, independent of the cause. CRP levels were measured with a sensitive standard assay on a Nephelometer analyser. Patients were classified on admission and discharge following New York Heart Association (NYHA) functional criteria; left ejection fraction was also determined by transthoracic echocardiography. Patients presenting clear sources of infection or inflammatory disease were excluded. Our control group consisted of patients admitted for syncope. Each patient was followed up through a computer system controlling admissions to and discharge from the hospital, for a period of 18 months after initial admission. End points considered were NYHA functional class on discharge, readmission and death.
Results: We studied prospectively 76 patients with a mean age of 73.5±11 [95% confidence interval (CI) 71.2–75.8]; 44 were male (58%) and 32 female (42%). The mean CRP level in patients with heart failure was 3.94±5.87 (95% CI, 1.26–7.60), while in 15 patients with syncope it was 0.84±1.95 (95% CI, 0.96–2.94) (P=0.0007). The principal causes of heart failure included dilated cardiomyopathy due to coronary arterial disease (30%), valvular disease (28%) and heart failure secondary to hypertension (25%). The mean left ejection fraction adequately measured in 72 (95%) patients was 50.41±9.88 (95% CI, 41.20–59.65). We observed a trend of higher CRP levels in relation to ejection fractions below 35%: 7.50±9.88 vs. 3.75±4.57, (P=0.09). Our results showed that on discharge CRP levels increased in relation to NYHA class: I: 0.74±0.69; II: 3.78±3.76; III: 7.4±8.65; IV: 12.2±15.27 (P<0.05). On follow-up of each patient for 18 months, 32 (43%) were readmitted due to deterioration of their heart condition. For patients who were readmitted, those presenting CRP levels >0.9 mg/dl were identified as candidates for earlier hospitalisation than those with levels below 0.9 mg/dl (P=0.02) RR=1.43. In logistic-regression analysis the only group of tested variables predicting readmission were levels of CRP, NYHA class and plasmatic K on discharge and left ventricle ejection fraction. Analysis of covariates yields CRP levels as being an independent predictor of readmission.
Conclusions: An inflammatory response is present in deteriorating heart failure. We observed higher CRP levels in patients with higher NYHA functional class, perhaps signalling a poor therapeutic response. Higher CRP levels were also related to higher rates of readmission and mortality and it could be an independent marker of improvement and readmission in heart failure.
Key Words: C-reactive protein • Heart failure • Chronic inflammatory response
Received May 22, 2001; Revised August 31, 2001; Accepted October 23, 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Zemljic, M. Bunc, and B. Vrtovec Trimetazidine Shortens QTc Interval in Patients With Ischemic Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2010; 15(1): 31 - 36. [Abstract] [PDF]
|
|
|
|
 |
|
 H. T. May, B. D. Horne, J. F. Carlquist, X. Sheng, E. Joy, and A. P. Catinella Depression After Coronary Artery Disease Is Associated With Heart Failure J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1440 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tracchi, G. Ghigliotti, M. Mura, S. Garibaldi, P. Spallarossa, C. Barisione, V. Boasi, M. Brunelli, L. Corsiglia, A. Barsotti, et al. Increased neutrophil lifespan in patients with congestive heart failure Eur J Heart Fail, April 1, 2009; 11(4): 378 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Collinson Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death: Just Another Brick in the Wall? Clin. Chem., February 1, 2009; 55(2): 203 - 205. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Williams, S. J. Shah, S. Ali, B. Y. Na, N. B. Schiller, and M. A. Whooley C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study Eur J Heart Fail, January 1, 2008; 10(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, and A. L. Clark Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study Eur J Heart Fail, October 1, 2006; 8(6): 658 - 661. [Abstract] [Full Text] [PDF]
|
|